867
Views
117
CrossRef citations to date
0
Altmetric
Reviews

Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes

, PharmD PhD
Pages 689-699 | Published online: 05 Apr 2010

Bibliography

  • Andrade SE, Gurwitz JH, Davis RL, Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191(2):398-407
  • Glover DD, Amonkar M, Rybeck BF, Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003;188(4):1039-45
  • Tatum WO, Liporace J, Benbadis SR, Updates on the treatment of epilepsy in women. Arch Intern Med 2004;164(2):137-45
  • Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006;107(5):1120-38
  • Dombrowski MP, Schatz M. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol 2008;111(2 Pt 1):457-64
  • Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005;294(21):2751-7
  • Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005;44(10):989-1008
  • Dawes M, Chowienczyk PJ. Drugs in pregnancy. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 2001;15(6):819-26
  • Hodge LS, Tracy TS. Alterations in drug disposition during pregnancy: implications for drug therapy. Expert Opin Drug Metab Toxicol 2007;3(4):557-71
  • Best BM, Mirochnick M, Capparelli EV, Impact of pregnancy on abacavir pharmacokinetics. AIDS 2006;20(4):553-60
  • Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990;18(1):20-36
  • Israili ZH, Dayton PG. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab Rev 2001;33(2):161-235
  • Baylis C. Glomerular ultrafiltration in the pseudopregnant rat. Am J Physiol 1982;243(3):F300-5
  • Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997;33(5):328-43
  • Little BB. Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. Obstet Gynecol 1999;93(5 Pt 2):858-68
  • Hebert MF, Carr DB, Anderson GD, Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol 2005;45(1):25-33
  • Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications. 2nd edition. Philadelphia: Lea & Febiger, 1989
  • Nakai A, Sekiya I, Oya A, Assessment of the hepatic arterial and portal venous blood flows during pregnancy with Doppler ultrasonography. Arch Gynecol Obstet 2002;266(1):25-9
  • Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002;301(2):594-8
  • Gerdin E, Salmonson T, Lindberg B, Maternal kinetics of morphine during labour. J Perinat Med 1990;18(6):479-87
  • Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61(6 Suppl 2):S35-42
  • Anderson GD. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 2005;14(1):19-29
  • Shimada T, Yamazaki H, Mimura M, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270(1):414-23
  • Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000;40:581-616
  • Hollenberg PF. Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metab Rev 2002;34(1-2):17-35
  • Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 2000;347(Pt 2):321-37
  • Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 2007;47(5):566-78
  • Honkakoski P, Zelko I, Sueyoshi T, The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 1998;18(10):5652-8
  • di Masi A, Marinis ED, Ascenzi P, Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol Aspects Med 2009;30(5):297-343
  • Dixit SG, Tirona RG, Kim RB. Beyond CAR and PXR. Curr Drug Metab 2005;6(4):385-97
  • Cunningham FG. Williams obstetrics. 21st edition. McGraw-Hill Medical Publishing Division, New York; 2001
  • Holinka CF, Diczfalusy E, Coelingh Bennink HJ. Estetrol: a unique steroid in human pregnancy. J Steroid Biochem Mol Biol 2008;110(1-2):138-43
  • Jeong H, Choi S, Song JW, Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. Xenobiotica 2008;38(1):62-75
  • Chen H, Yang K, Choi S, Upregulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17{beta}-Estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy. Drug Metab Dispos 2009;37(9):1841-7
  • Koh K, Jeong H. Effects of 17beta-estradiol (E2) on expression of CYP enzymes in human hepatocytes. Drug Metab Rev 2009;41(Suppl 3):49
  • Higashi E, Fukami T, Itoh M, Human CYP2A6 is induced by estrogen via estrogen receptor. Drug Metab Dispos 2007;35(10):1935-41
  • Kawamoto T, Kakizaki S, Yoshinari K, Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol Endocrinol 2000;14(11):1897-905
  • Yang K, Koh K, Choi S, CAR (constitutive androstane/active receptor)-mediated up-regulation of CYP2B6 expression by 17 b-estradiol. Drug Metab Rev 2009;41(Suppl 3):89
  • Korenman SG. Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids 1969;13(2):163-77
  • Martucci C, Fishman J. Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3, 15alpha,16alpha,17beta-tetrol). Steroids 1976;27(3):325-33
  • Visser M, Coelingh Bennink HJ. Clinical applications for estetrol. J Steroid Biochem Mol Biol 2009;114(1-2):85-9
  • Watson CS, Jeng YJ, Kochukov MY. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J 2008;22(9):3328-36
  • Ekena K, Katzenellenbogen JA, Katzenellenbogen BS. Determinants of ligand specificity of estrogen receptor-alpha: estrogen versus androgen discrimination. J Biol Chem 1998;273(2):693-9
  • Gorodeski GI, Pal D. Involvement of estrogen receptors alpha and beta in the regulation of cervical permeability. Am J Physiol Cell Physiol 2000;278(4):C689-96
  • Hirano S, Furutama D, Hanafusa T. Physiologically high concentrations of 17beta-estradiol enhance NF-kappaB activity in human T cells. Am J Physiol Regul Integr Comp Physiol 2007;292(4):R1465-71
  • Attardi BJ, Zeleznik A, Simhan H, Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol 2007;197(6):599 e1-7
  • Thomas HV, Murphy MF, Key TJ, Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Hum Biol 1998;25(1):69-75
  • Potischman N, Troisi R, Thadhani R, Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14(6):1514-20
  • Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15(11):2123-30
  • Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002;143(1):205-12
  • Moyer DL, Felix JC. The effects of progesterone and progestins on endometrial proliferation. Contraception 1998;57(6):399-403
  • Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol 2008;83:1-10
  • O'Connell MB, Frye RF, Matzke GR, Effect of conjugated equine estrogens on oxidative metabolism in middle-aged and elderly postmenopausal women. J Clin Pharmacol 2006;46(11):1299-307
  • Lamba V, Lamba J, Yasuda K, Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther 2003;307(3):906-22
  • Zhang H, Wu X, Wang H, Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol Pharmacol 2008;74(3):714-23
  • Fuglsang J, Ovesen P. Aspects of placental growth hormone physiology. Growth Horm IGF Res 2006;16(2):67-85
  • Waxman DJ, O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 2006;20(11):2613-29
  • Waxman DJ, Holloway MG. Centennial perspective: sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009;76(2):215-28
  • Thangavel C, Garcia MC, Shapiro BH. Intrinsic sex differences determine expression of growth hormone-regulated female cytochrome P450s. Mol Cell Endocrinol 2004;220(1-2):31-9
  • Holloway MG, Miles GD, Dombkowski AA, Liver-specific hepatocyte nuclear factor-4alpha deficiency: greater impact on gene expression in male than in female mouse liver. Mol Endocrinol 2008;22(5):1274-86
  • Dhir RN, Dworakowski W, Thangavel C, Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther 2006;316(1):87-94
  • Liddle C, Goodwin BJ, George J, Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 1998;83(7):2411-6
  • Sinues B, Mayayo E, Fanlo A, Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children. Eur J Clin Pharmacol 2004;60(8):559-64
  • Cheung NW, Liddle C, Coverdale S, Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man. J Clin Endocrinol Metab 1996;81(5):1999-2001
  • Jaffe CA, Turgeon DK, Lown K, Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am J Physiol Endocrinol Metab 2002;283(5):E1008-15
  • Jurgens G, Lange KH, Reuther LO, Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Clin Pharmacol Ther 2002;71(3):162-8
  • Forsyth IA, Wallis M. Growth hormone and prolactin-molecular and functional evolution. J Mammary Gland Biol Neoplasia 2002;7(3):291-312
  • Creasy RK, Resnik R, Iams JD. Maternal-fetal medicine: principles and practice. 5th edition.: Saunders, Philadelphia, PA, USA; 2004
  • Luquita MG, Catania VA, Sanchez-Pozzi EJ, Prolactin increases the hepatic content of mu-class subunits of glutathione S-transferase in the rat. Drug Metab Dispos 1999;27(1):122-4
  • Luquita MG, Sanchez Pozzi EJ, Catania VA, Analysis of p-nitrophenol glucuronidation in hepatic microsomes from lactating rats. Biochem Pharmacol 1994;47(7):1179-85
  • Luquita MG, Catania VA, Sanchez-Pozzi EJ, Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats. J Pharmacol Exp Ther 1996;278(2):921-5
  • Luquita MG, Catania VA, Pozzi EJ, Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver. J Pharmacol Exp Ther 2001;298(1):49-56
  • Ganguly TC, O'Brien ML, Karpen SJ, Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5. J Clin Invest 1997;99(12):2906-14
  • Cao J, Gowri PM, Ganguly TC, PRL, placental lactogen, and GH induce NA(+)/taurocholate-cotransporting polypeptide gene expression by activating signal transducer and activator of transcription-5 in liver cells. Endocrinology 2001;142(10):4212-22
  • Liu Y, Hyde JF, Vore M. Prolactin regulates maternal bile secretory function post partum. J Pharmacol Exp Ther 1992;261(2):560-6
  • Greenspan FS, Gardner DG. Basic & clinical endocrinology. 7th edition. Lange Medical Books/McGraw-Hill, New York; 2004
  • Gabbe SG, Niebyl JR, Simpson JL. Obstetrics: normal and problem pregnancies. 5th edition. Churchill Livingstone/Elsevier, Philadelphia, PA, USA; 2007
  • Soldin OP, Guo T, Weiderpass E, Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry. Fertil Steril 2005;84(3):701-10
  • Pascussi JM, Gerbal-Chaloin S, Drocourt L, The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 2003;1619(3):243-53
  • LeCluyse E, Madan A, Hamilton G, Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J Biochem Mol Toxicol 2000;14(4):177-88
  • Pascussi JM, Drocourt L, Gerbal-Chaloin S, Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 2001;268(24):6346-58
  • Pascussi JM, Gerbal-Chaloin S, Fabre JM, Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 2000;58(6):1441-50
  • Pascussi JM, Drocourt L, Fabre JM, Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 2000;58(2):361-72
  • Sugatani J, Nishitani S, Yamakawa K, Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol Pharmacol 2005;67(3):845-55
  • Borlakoglu JT, Scott A, Henderson CJ, Alterations in rat hepatic drug metabolism during pregnancy and lactation. Biochem Pharmacol 1993;46(1):29-36
  • Turcan RG, Tamburini PP, Gibson GG, Drug metabolism, cytochrome P450 spin state, and phospholipid changes during pregnancy in the rat. Biochem Pharmacol 1981;30(11):1223-5
  • Neale MG, Parke DV. Effects of pregnancy on the metabolism of drugs in the rat and rabbit. Biochem Pharmacol 1973;22(12):1451-61
  • Vore M, Soliven E. Hepatic estrone and estradiol glucuronyltransferase activity in pregnancy. Induction by pretreatment with 3-methylcholanthrene and phenobarbital. Drug Metab Dispos 1979;7(5):247-51
  • He XJ, Yamauchi H, Suzuki K, Gene expression profiles of drug-metabolizing enzymes (DMEs) in rat liver during pregnancy and lactation. Exp Mol Pathol 2007;83(3):428-34
  • Masuyama H, Hiramatsu Y, Mizutani Y, The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Mol Cell Endocrinol 2001;172(1-2):47-56
  • Ochs H, Dusterberg B, Gunzel P, Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res 1986;46(3):1224-32
  • First principles of gastroenterology: the basis of disease and an approach to management. 2nd edition. Ottawa, Ontario, Canada: Canadian Public Health Association; 1992
  • Shaikh AA. Estrone and estradiol levels in the ovarian venous blood from rats during the estrous cycle and pregnancy. Biol Reprod 1971;5(3):297-307
  • Dean ME, Stock BH. Hepatic microsomal metabolism of drugs during pregnancy in the rat. Drug Metab Dispos 1975;3(5):325-31
  • Graham MJ, Lake BG. Induction of drug metabolism: species differences and toxicological relevance. Toxicology 2008;254(3):184-91
  • Cunningham F, Levono K, Bloom S, Williams obstetrics. 22nd edition. New York, USA: McGraw-Hill; 2005
  • Yallampalli C, Chauhan M, Thota CS, Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity. Trends Endocrinol Metab 2002;13(6):263-9
  • Lambert GH, Lietz HW, Kotake AN. Effects of pregnancy on the cytochrome P-450 system in mice. Biochem Pharmacol 1987;36(12):1965-71

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.